Dalton Transactions
DOI: 10.1039/C6DT02202B
3
2
(
dq, JHH = 7 Hz, JHH = 14.5 Hz, 1H), 3.22-3.29 (m, 2H), 3.53 (dq, b:5,1-b']bis[1,3]oxazol-4-ylidene-borane
(21),
(3S,7S)-3,7-di-
3
2
11
J
= 7 Hz, J = 16 Hz, 1H). B NMR (CD Cl ): -16.7 (s), 89.1 (bs). isopropyl-2,3,7,8-tetrahydroimidazo[4,3-b:5,1-b']bis[1,3]oxazol-4-
C{ H} NMR (CD
bs), 31.2 (bs), 31.5, 35.7, 36.0, 36.3, 36.4, 39.5, 40.0, 46.4, 48.6, 2,3,7,8-tetrahydroimidazo[4,3-b:5,1-b']bis[1,3]oxazol-4-ylidene-
6.2, 69.4, 136.5 (d, JCF = 237 Hz), 138.2 (d, JFC = 240 Hz), 148.4 (d, (9-borabicyclo[3.3.1]-nonane) (23): These compounds were
FC = 238 Hz) 171.3.4. F NMR (CD
HH
HH
2
2
1
3
1
2 2
Cl ): 13.3, 13.3, 16.3, 16.7, 20.4, 21.8, 22.0, 30.9 ylidene-(dicyclohexylchloroborane) (22), (3S,7S)-3,7-di-tertbutyl-
(
1
1
6
1
19
3
J
2
Cl
2
): -133.1 (bs), -163.7 (t, JFF
=
prepared in a similar fashion and thus one preparation is detailed.
3
+
2
0 Hz), -167.6 (t,
J
FF = 18 Hz). HRMS(ESI+): C21
H
38BN
2
, [M ] m/z Triflate salt 18 (110 mg, 0.285 mmol) and 9-BBN dimer (35 mg,
(
2 3 2
calc.): 329.3123, m/z (obs.): 329.2739. Anal. Calcd. for C21H38BN : C 0.1425 mmol) were dissolved in 2.5 mL THF at -35 °C. K[N(SiMe )
5
3.60, H 3.80, N 2.78%; Obs. C 54.21, H 2.60, N 2.50%.
(58 mg, 0.29 mmol) were dissolved in 2 mL THF at -35 °C and the
solution was added dropwise to the mixture. The mixture was
stirred overnight at room temperature and the volatiles were
removed in vacuo. The residue was extracted with pentane, filtered
through Celite, and dried to a light yellow powder. Crystals for a
1
1
1
1
1
1
4: Yield: 276 mg (0.26 mmol, 93 %). H NMR (CD
2
Cl
2
): 1.09 (s, 3H),
3
3
.15 (s, 3H), 1.26 (d, JHH = 6.5 Hz, 3H), 1.34 (d, JHH = 6.5 Hz, 3H),
.46 (d, JHH = 6.8 Hz, 3H), 1.53 (s, 3H), 1.61 (d, JHH = 6.8 Hz, 3H),
3
3
.64-1.70 (m, 1H), 1.78-1.81 (bm, 1H), 1.81-1.85 (bm, 2H), 1.87-
single crystal X-ray study were obtained by slow evaporation of
.89 (bm, 1H), 1.90-1.94 (bm, 2H), 2.03-2.13 (m, 3H), 2.23-2.39
1
3
pentane. Yield: 20 (60 mg, 0.167 mmol, 58%) H NMR (benzene-d
6
):
(
bm, 7H), 2.55-2.61 (m, 1H), 2.68 (sept,
J
HH = 6.8 Hz, 1H), 3.10
3
4
2
3
3
3
11
4.10 (ddd, JHH = 7 Hz, JHH = 3 Hz, JHH = 1 Hz, 2H), 3.92 (dd, JHH = 9
Hz, JHH = 1 Hz, 2H), 3.72 (ddd, JHH = 9 Hz, JHH = 7 Hz, JHH = 1 Hz,
H), 2.77-1.87 (m, 15H), 1.52-1.41 (m, 2H), 0.63 (d, JHH = 7 Hz, 6H),
0.44 (d, JHH = 7.0 Hz, 6H). B NMR (benzene-d
Hz). C NMR (benzene-d ): 124.0, 75.7, 62.3, 37.0, 36.6, 33.6, 30.0,
26.5, 26.0, 18.6, 14.6. MS (DART) m/z: 357 [M-H] . HRMS (ESI+):
(
sept, JHH = 7 Hz, 1H), 3.32 (d, JHH = 5 Hz, 1H). B NMR (CD
2
Cl
): 13.9, 16.2, 16.8, 19.3, 19.7,
0.3, 21.3, 21.6, 21.8, 29.2, 29.4, 33.0, 35.5, 35.7, 36.4, 36.5, 39.7,
2
): -
3
4
3
2
1
3
1
2
4
2
6.7 (s), 85.8 (bs). C NMR (CD
2
Cl
2
3
2
3
11
1
1
1
6
): -16.9 (d, JBH = 83
0.6, 55.9, 59.8, 61.0, 71.4, 136.1 (d, JCF = 242 Hz), 138.0 (d, JCF
=
13
1
19
6
40 Hz), 148.2 (d, JCF = 241 Hz), 171.6.5. F NMR (CD
2
Cl
2
): -133.1
+
3
3
(
bs), -163.8 (t, JFF = 21 Hz), -167.6 (t, JFF = 18 Hz). HRMS (ESI+):
+
+
[M ] m/z (calc.): C21
2 2
H34BN O 357.2713 (obs): 357.2724. Anal. Calc.
23 2
C H42BN , [M ] m/z (calc.): 356.3472, m/z (obs.): 356.3477.
for C21 : C 70.39, H 9.85, N 7.82%. Found: C 69.30, H 9.34,
2 2
H35BN O
Synthesis of (1S,4R,6R)-2,5-dialkyl-6,9,9-trimethyl-2,5-diaza-3- N 7.42%
borabicyclo[4.2.1]nonanes (alkyl = Me: 15, Et: 16, iPr: 17): These
2
1: Crystals for a single crystal X-ray study were obtained by slow
compounds were prepared in a similar fashion and thus one
preparation is detailed. 50 mg of the borane adduct 12 (0.17 mmol)
were dissolved in 4 mL pentane and heated to 50-110 °C for 4-16 h.
The solvent was then removed in vacuo to provide the pure
evaporation from toluene. Yield: (44 mg, 0.176 mmol, 62%).
1
6
H NMR (benzene-d ): 4.06-3.91 (m, 4H), 3.86-3.74 (m, 2H), 2.89
3
4
3
(
ddq, JHH = 10 Hz, JHH = 7 Hz, JHH = 4 Hz, 2H), 2.40-1.65 (m, 1H),
3
3
11
0
d
2
C
.65 (d, JHH = 7 Hz, 6H), 0.44 (d, JHH = 7 Hz, 6H). B NMR (benzene-
product 15 in quantitative yield as a white solid. Yield: 50 mg
1
13
1
6
): -35.6 (q, JBH = 88 Hz). C NMR (benzene-d
6
): 76.1, 61.1, 29.0,
2.7, 18.3, 14.3. MS (DART) m/z: 249 [M-H] . HRMS (ESI): (calc.). for
2 2
249.1774, (obs): 249.1771. Anal. Calc. for C13H23BN O :
(
0.17 mmol, >99%). H NMR (benzene-d
6
): 0.78 (s, 3H), 0.97 (s, 3H),
+
1
1
2
.15 (s, 3H), 1.35-1.42 (m, 1H), 1.53-1.60 (m, 4H), 1.63-1.95 (m,
3H), 2.09-2.25 (m, 3H), 2.38 (bs, 1H), 2.53 (bs, 1H), 2.59 (s, 3H),
13
H
22BN
2
O
2
3
11
C 62.42, H 9.27, N 11.20%. Found: C 62.02, H 9.27, N 11.10%.
.62 (d, JHH = 5 Hz, 1H), 2.64 (s, 3H). B NMR (benzene-d
6
): 44.2
1
3
1
(
bs). C{ H} NMR (benzene-d
6
): 5.0, 16.6, 20.6, 21.8, 22.7, 24.9 (bs), 22: Crystals for a single crystal X-ray study were obtained by slow
5.6, 28.4, 30.5, 30.8, 34.2, 35.2, 38.3, 38.5, 40.1, 41.0, 44.5, 67.6, evaporation of toluene. Yield: (50 mg, 0.111 mmol, 35%). H NMR
1
2
6
3
+
3
2
3
8.7 (bs), 69.8, 79.2. HRMS(ESI+): C19
02.3002, m/z (obs.): 302.3003.
2 6
H36BN , [M ] m/z (calc.): (benzene-d ): 4.56 (dd, JHH = 7 Hz, JHH = 2 Hz, 2H), 3.91 (dd, JHH = 9
3
4
3
2
Hz, JHH = 1 Hz, 2H), 3.71 (ddd, JHH = 9 Hz, JHH = 7 Hz, JHH = 1 Hz,
2H), 3.02 (dtd, JHH = 14 Hz, JHH = 7 Hz, JHH = 3 Hz, 2H), 2.39 (bs,
1H), 2.36 (bs, 1H), 2.09-0.95 (m, 18H), 0.68 (d, JHH = 7 Hz, 6H), 0.55
3
3
4
1
1
3
1
2
3
6: Yield: 20 mg (0.06 mmol, >99%). H NMR (benzene-d
6
): 0.81 (s,
3
3
3
H), 0.85 (s, 3H), 0.92 (t, JHH = 7 Hz, 3H), 1.20 (t, JHH = 7 Hz, 3H),
.22 (s, 3H), 1.36-1.43 (m, 1H), 1.53-2.01 (m, 15H), 2.12-2.24 (m,
H), 2.43-2.58 (m, 3H), 2.64 (d, J = 5 Hz, 1H), 2.69 (s, 1H), 3.20-
.35 (m, 2H). B NMR (benzene-d
3
11
13
(
d,
(benzene-d
29.6, 29.5, 28.4, 28.3, 28.2, 28.0, 18.7, 14.4. MS (DART) m/z: 413
J
HH = 7 Hz, 6H). B NMR (benzene-d
6
): 3.2 (bs). C NMR
3
6
): 75.9, 64.5, 32.8, 32.4, 31.4, 31.2, 31.1, 30.2, 29.7,
HH
11
13
1
6
): 44.0 (bs). C{ H} NMR
+
[
M-Cl] . HRMS (ESI): calc. for C H BN O 413.33393, found
25 42 2 2
(
benzene-d ): 14.3, 15.7, 17.1, 18.2, 21.7, 29.8, 30.6, 30.8, 31.0,
6
4
13.33381.
3
7
1.5, 37.6, 38.8, 39.0, 39.3, 41.8, 42.5, 46.9, 47.3, 50.4, 51.9, 66.3,
+
6.2. HRMS (ESI+): C H BN , [M ] m/z (calc.): 328.3164, m/z 23: Crystals for a single crystal X-ray study were obtained by slow
2
1
38
2
1
(
2
obs.): 328.3175. Anal. Calcd. for C21H38BN : C 76.35, H 11.90, N evaporation of pentane. Yield: (88 mg, 0.228 mmol, 80%). H NMR
3
3
8
.48%; Obs. C 76.57, H 11.63, N 8.09%.
(benzene-d ): 4.15 (d, J
3.78 (dd, JHH = 9 Hz, JHH = 6 Hz, 2H), 2.82-1.74 (m, 14H), 1.55 (bs,
= 5 Hz, 2H), 4.04 (d, J
= 9 Hz, 2H),
6
HH
HH
3
3
1
1
3
1
7: Yield: 45 mg (0.13 mmol, >99%). H NMR (benzene-d
6
): 0.74 (s,
11
3
3
1H), 1.16 (bs, 1H), 0.88 (s, 18H). B NMR (benzene-d
6
): -16.4 (d,
): 124.3, 78.6, 68.3, 39.4, 35.3,
33.1, 32.4, 27.5, 26.6, 25.9. MS (ESI+) m/z: 385 [M-H]+. HRMS (ESI):
(calc.) for C23 + 385.3026, (obs): 386.3032. Anal. Calc. for
H), 0.85 (s, 3H), 0.86 (d, J =7 Hz, 3H), 1.00 (d, J = 7 Hz, 3H),
.22 (d, JHH = 7 Hz, 6H), 1.25 (s, 3H), 1.49-1.55 (m, 2H), 1.71-1.81
m, 6H), 1.86-1.97 (m, 6H), 2.23-2.32 (m, 3H), 2.94 (d, J = 6 Hz,
HH
H), 3.31 (s, 1H), 3.49 (sept, JHH = 7 Hz, 1H), 3.93 (sept, JHH = 7 Hz,
H). B NMR (benzene-d ): 44.0 (bs). C{ H} NMR (benzene-d ):
0.7, 21.3, 21.9, 22.1, 23.8, 25.0 (bs), 25.4, 27.1, 28.2, 29.0, 31.3,
1
13
HH
HH
3
JBH = 86 Hz), C NMR (benzene-d
6
3
(
3
3
2 2
H38BN O
1
1
2
3
1
1
13
1
C
6
23
H
39BN
2
O
2
: C 71.50, H 10.17, N 7.25%. Found: C 70.45, H 10.16, N
6
6
.79%
2.2, 33.2, 33.4, 42.0, 47.2, 48.1, 48.6, 49.6, 54.6 (bs), 66.9, 70.0. Synthesis of
1,3-dimethylimidazol-2-ylidene-di-(1S,2R,3S,5S)-
+
HRMS (ESI+): C23
H42BN
2
,
[M ] m/z (calc.): 356.3477, (obs.): isopinocampheylborane (24), 1,3-diisopropylimidazol-2-ylidene-
(25), 1-benzyl-3-
3
56.3484. Anal. Calcd. for C H BN : C 77.08, H 12.04, N 7.82%; di-(1S,2R,3S,5S)-isopinocampheylborane
2
3
42
2
Obs. C 77.10, H 12.36, N 7.75%.
methylimidazol-2-ylidene-di-(1S,2R,3S,5S)-isopinocampheylbor-
ane (26), 1-methyl-3-phenylimidazol-2-ylidene-di-(1S,2R,3S,5S)-
isopinocampheylborane (27), 1-tert-butyl-3-methylimidazol-2-
Synthesis of (3S,7S)-3,7-di-isopropyl-2,3,7,8-tetrahydroimidazo-
[
4,3-b:5,1-b']bis[1,3]oxazol-4-ylidene-(9-borabicyclo[3.3.1]-no-
ylidene-di-(1S,2R,3S,5S)-isopinocampheylborane
(28):
These
nane) (20), (3S,7S)-3,7-di-isopropyl-2,3,7,8-tetrahydroimidazo[4,3-
4